Kiora Pharmaceuticals's total assets for Q1 2025 were $34.02M, a decrease of -6.76% from the previous quarter. KPRX total liabilities were $10.32M for the fiscal quarter, a -3.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.